Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial

Citation
Mj. Wawer et al., Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial, LANCET, 353(9152), 1999, pp. 525-535
Citations number
37
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
353
Issue
9152
Year of publication
1999
Pages
525 - 535
Database
ISI
SICI code
0140-6736(19990213)353:9152<525:COSTDF>2.0.ZU;2-2
Abstract
Background The study tested the hypothesis that community-level control of sexually transmitted disease (STD) would result in lower incidence of HIV-1 infection in comparison with control communities. Methods This randomised, controlled, single-masked, community-based trial o f intensive STD control, via home-based mass antibiotic treatment, took pla ce in Rakai District, Uganda. Ten community clusters were randomly assigned to intervention or control groups. All consenting residents aged 15-59 yea rs were enrolled; visited in the home every 10 months; interviewed; asked t o provide biological samples for assessment of HIV-1 infection and STDs; an d were provided with mass treatment (azithromycin, ciprofloxacin, metronida zole in the intervention group, vitamins/anthelmintic drug in the control). intention-to-treat analyses used multivariate, paired, cluster-adjusted ra te ratios. Findings The baseline prevalence of HIV-1 infection was 15.9%. 6602 HIV-1-n egative individuals were enrolled in the intervention group and 6124 in the control group. 75.0% of intervention-group and 72.6% of control-group part icipants provided at least one follow-up sample for HIV-1 testing. At enrol ment, the two treatment groups were similar in STD prevalence rates. At 20- month follow-up, the prevalences of syphilis (352/6238 [5.6%) vs 359/5284 [ 6.8%]; rate ratio 0.80 [95% CI 0.71-0.89]) and trichomoniasis (182/1968 [9. 3%] vs 261/1815 [14.4%]; rate ratio 0.59 [0.38-0.91]) were significantly lo wer in the intervention group than in the control group. The incidence of H IV-1 infection was 1.5 per 100 person-years in both groups (rate ratio 0.97 [0.81-1.16]). In pregnant women, the follow-up prevalences of trichomonias is, bacterial vaginosis, gonorrhoea, and chlamydia infection were significa ntly lower in the intervention group than in the control group. No effect o f the intervention on incidence of HIV-1 infection was observed in pregnant women or in stratified analyses. Interpretation We observed no effect of the STD intervention on the inciden ce of HIV-1 infection. In the Rakai population, a substantial proportion of HIV-1 acquisition appears to occur independently of treatable STD cofactor s.